ISPOR 16th Annual International Meeting - Plenary Sessions

Monday, May 23, 2011
9:00 AM-10:30 AM
Health Care Reform in the United States - One Year Later

In 2010, US Congress passed major health care reform legislation [the "Affordable Care Act" and the "Reconciliation Act"]. The Medicare prescription drug "doughnut hole" will be phased out. Employers will be penalized if they do not offer health care coverage and US citizens are required to have "health care coverage" by 2014. Small businesses can purchase qualified coverage via state-based health insurance exchanges by 2014. How will these changes affect health care management organizations and providers and health technology producers (drug, device, and diagnostics)? What is the clinical impact of this law? What is the impact of this act on outcomes research? These questions will be addressed during this plenary session as well as a legal and political analysis of this law will be presented.

Mark S. Roberts, MD, MPP, Professor and Chair, Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health & Professor of Medicine, Industrial Engineering and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, USA

Robert I. Field, JD, MPH, PhD, Professor of Law, Earle Mack School of Law at Drexel University, Professor of Health Management and Policy, Drexel University School of Public Health, Philadelphia, PA, USA

Allan M. Korn, MD, Senior Vice President, Chief Medical Officer, Office of Clinical Affairs, Blue Cross and Blue Shield Association, Chicago, IL, USA
Steve E. Phurrough, MD, MPA, Chief Operating Officer and Senior Clinical Director, Center for Medical Technology Policy, Baltimore, MD, USA


Tuesday, May 24, 2011
11:30 AM - 12:45 PM
Evolution of Comparative Effectiveness Research: Learning from the Past; Challenges for the Future

In the American Recovery and Reinvestment Act (ARRA) of 2009, US Congress appropriated $1.1 billion to jump-start the nation's efforts to accelerate comparative effectiveness research (CER). How were these funds spent? How will the results from these studies impact health care decisions? In the Patient Protection and Affordable Care Act of 2010, US Congress established the Patient-Centered Outcomes Research Institute (PCORI) to identify priorities for and establish, update and carry out a national comparative outcomes research project agenda. What will be the process for developing research priorities? Who will be conducting the research? Will the study results impact health care? These questions will be addressed during this plenary session.

J. Sanford (Sandy) Schwartz, MD, Leon Hess Professor of Medicine, Health Care Management and Economics, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA
Carolyn M. Clancy, MD, Director, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Rockville, MD, USA
Bruce M. Psaty, MD, PhD, Professor, Medicine, Epidemiology and Health Services, University of Washington and Investigator, Group Health Research Institute, Group Health Cooperative, Seattle, WA, USA
Wednesday, May 25, 2011
10:00 AM -11:30 AM
Modeling Good Research Practices - Everything You Need To Know

ISPOR and the Society for Medical Decision Making (SMDM) are jointly developing a series of reports on good research practices (preferred practices) for modeling. These reports address contentious modeling issues, conceptual framework for modeling, discrete event simulation, state-based and dynamic modeling, parameter estimation and uncertainty, as well as transparency and validation of models. The ISPOR-SMDM recommendations for modeling preferred practices as well as contentious issues will be presented during this plenary session.

Jens Grueger PhD, Vice President, Head Global Market Access Pfizer Ltd, London, UK
Modeling Task Force Recommendations
Speaker: J. Jaime Caro, MDCM, FRCPC, FACP, Chair, ISPOR-SMDM Modeling Good Research Practices Task Force, and Senior Vice President, Health Economics, United BioSource Corporation, Lexington, MA, USA
Conceptualizing A Model: Questions You Should Be Asking
Speaker: Mark Roberts MD, Chair, Conceptual Modeling and Data Source Preparation Working Group, and Professor and Chair, Department of Health Policy & Management, University of Pittsburgh, Pittsburgh, PA, USA
Addressing Uncertainty
Speaker: Andrew Briggs, DPhil, Co-Chair, ISPOR-SMDM Modeling Good Research Practices Task Force, and Co-Chair, Model Parameter Estimation and Uncertainty Working Group, and Lindsay Chair in Health Policy & Economic Evaluation, Public Health & Health Policy, University of Glasgow, Glasgow, Scotland UK
Validation and Reporting
Speaker: David Eddy PhD, MD, Co-Chair, Model Transparency and Validation Working Group, and Founder and Medical Director, Archimedes, Inc., San Francisco, CA USA
State Transition Models
Speaker: Uwe Siebert, MD, MPH, MSc, ScD, Co-Chair, ISPOR-SMDM Modeling Good Research Practices Task Force, and Co-Chair, State-Transition Working Group, and Professor of Public Health, UMIT – Univ. of Health Sciences, Medical Informatics & Technology, Hall i.T, Austria
Discrete Event Simulation
Speaker: Jonathan Karnon PhD, Co-Chair, Discrete Event Simulation Working Group, and Professor in Health Economics, University of Adelaide, Adelaide, South Australia
Dynamic Transmission Models
Speaker: Richard Pitman PhD, Co-Chair, Dynamic Transmission Modeling Working Group, and, Senior Health Economist, Oxford Outcomes Ltd., Oxford, UK